Ugur Sahin – författare

Winners of the Paul Ehrlich PrizeThe dramatic story of the married scientists who founded BioNTech and developed the first vaccine against COVID-19.Nobody thought it was possible. In mid-January 2020, Ugur Sahin told Özlem Türeci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year. His confidence was built upon almost thirty years of research. While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA; they believed it could be harnessed to redirect the immune system''s forces against any number of diseases. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first; but by the time Sars-Cov-2 was discovered in Wuhan, China, BioNTech was prepared to deploy cutting edge technology and create the world’s first clinically approved inoculation for the coronavirus.The Vaccine draws back the curtain on one of the most important medical breakthroughs of our age; it will reveal how Doctors Sahin and Türeci were able to develop twenty vaccine candidates within weeks, convince Big Pharma to support their ambitious project, navigate political interference from the Trump administration and the European Union, and provide more than three billion doses of the Pfizer/BioNTech vaccine to countries around the world in record time.Written by Joe Miller—the Financial Times’ Frankfurt correspondent who covered BioNTech’s COVID-19 project in real time—with contributions from Sahin and Türeci, as well as interviews with more than sixty scientists, politicians, public health officials, and BioNTech staff, the book covers key events throughout the extraordinary year, as well as exploring the scientific, economic, and personal background of each medical innovation. Crafted to be both completely accessible to the average reader and filled with details that will fascinate seasoned microbiologists, The Vaccine explains the science behind the breakthrough, at a time when public confidence in vaccine safety and efficacy is crucial to bringing an end to this pandemic.

The dramatic story of the married scientists who founded BioNTech and developed the first vaccine against the COVID-19 pandemic.Nobody thought it was possible. In mid-January 2020, Ugur Sahin told Özlem Türeci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year. His confidence was built upon almost thirty years of research. While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA; they believed it could be harnessed to turn the human body into its own pharmacy. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first; but by the time Sars-Cov-2 was discovered in Wuhan, BioNTech was prepared to deploy cutting edge technology and create the world’s first approved inoculation for the coronavirus.The Vaccine draws back the curtain on one of the most important medical breakthroughs of our age; it will reveal how Doctors Sahin and Türeci were able to develop twenty vaccine candidates within weeks, convince Big Pharma to support their ambitious project, navigate political interference from the Trump administration and the European Union, and manage to provide more than two billion doses of the Pfizer/BioNTech vaccine to countries around the world in record time.Written by Joe Miller—the Financial Times’ Frankfurt correspondent who covered BioNTech’s COVID-19 project in real time—with contributions from Sahin and Türeci, as well as interviews with more than 50 scientists, politicians, public health officials, and BioNTech staff, the book covers key events throughout the extraordinary year, as well as exploring the scientific, economic, and personal background of each medical innovation. Crafted to be both completely accessible to the average listener and filled with details that will fascinate seasoned microbiologists, The Vaccine explains the science behind the breakthrough, at a time when public confidence in vaccine safety and efficacy is crucial to bringing an end to this pandemic.A Macmillan Audio production from St. Martin''s Press

When the world stopped, all hopes rested on finding a vaccine. An unlikely team answered the call. Before Covid-19 was even given its name, a select group of scientists in Germany, assembled by married couple and decades-long research partners Ugur Sahin and Özlem Türeci, began building 20 potential vaccines.As the deadly disease spread from country to country, what followed was a desperate race against time to conduct rigorous tests and clinical trials, whilst navigating political interference and seeking the support of the pharmaceutical industry.Shedding a light on the science behind the breakthrough, The Vaccine tells the story of the trailblazers who led the fightback against Covid-19, whose discoveries could now help the world tackle cancer, along with many other pervasive diseases. It draws back the curtain on one of the most important medical achievements of our age, containing contributions from the fascinating couple themselves, as well as more than 60 scientists, politicians, public health officials, and BioNTech staff.More suspenseful than a novel, this is a real-life story of an extraordinary race against time to save the world.

Kertomus vuosisadan lääketieteellisestä läpimurrosta ja pariskunnasta sen takana.

Kun koronapandemia pysäytti maailman, tehokkaan lääkkeen kehittämisen ennustettiin vievän parhaimmillaankin vuosia. Turkkilaistaustainen, tiedeyhteisön ylenkatsoma lääkäripariskunta sai rokotteen valmiiksi kahdessa kuukaudessa. Ihmeidentekijät on heidän tarinansa.

Istuessaan aamiaispöydässä tammikuussa 2020 Özlem Türeci ja Uğur Şahin kuulivat uutisen kulovalkean tavoin leviävästä tappavasta viruksesta. Urallaan he olivat omistautuneet syöpälääkkeiden kehittämiseen ja sovelsivat uutta mRNA-nimistä geenitekniikkaa, jota muu tiedeyhteisö piti haihatteluna. Pariskunta päätti valjastaa koko BioNtech-yrityksensä kehittämään rokotetta virusta vastaan. Vain kaksi kuukautta myöhemmin rokote oli valmis. Türecin ja Şahinin tarvitsi enää vakuuttaa muu maailma siitä, että heidän keksintönsä oli tehokas ja turvallinen, ja tehdä se ennen kuin virus aiheuttaisi lopullisen katastrofin. Nyt mRNA-tekniikasta povataan läpimurtoa myös syöpien, Alzheimerin taudin ja monen muun vakavan sairauden hoidossa.

Ihmeidentekijät on samalla tarina kahden ihmisen keskinäisestä rakkaudesta, yhteisestä intohimosta lääketiedettä kohtaan sekä heidän tiestään tulevaisuutta mullistavan yrityksen perustajiksi. Kirjan on kirjoittanut yhdessä Türecin ja Şahinin kanssa Financial Timesin toimittaja Joe Miller.